Respiratory Care |

Evaluation of a Noninvasive Respiration Monitor for Continuous Monitoring of Respiratory Parameters FREE TO VIEW

Jenny Freeman, MD; Samuel Galvagno, DO; Alexander Panasyuk, PhD; Michael Lalli, BS; Nicole Yocum, MA; Roman Bokhenik, BS; Lynn Desmarais, AAS; Darren Fahy, BS; Diane Ladd*, FNP
Chest. 2012;142(4_MeetingAbstracts):950A. doi:10.1378/chest.1389779
Text Size: A A A
Published online


SESSION TYPE: Respiratory Support Posters

PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 01:30 PM

PURPOSE: Respiratory monitoring in recently extubated patients is suboptimal. There is no clinically useful leading indicator of impending respiratory failure. A Respiratory Volume Monitor (RVM) has been developed to deliver continuous, real-time respiratory volume and rate data. This study aims to test the accuracy of the RVM monitor over a 24 hour period in a cohort of adult subjects.

METHODS: An impedance-based RVM system (ExSpiron, Respiratory Motion, Inc., Waltham, MA) was tested by comparing RVM respiratory signals with simultaneous readings obtained from a monitoring spirometer (Wright Respirometer, nSpire Health, Inc., Longmont, CO) collected during normal breathing (60 adult subjects, 138 visits, 1752 tests) over a 24 hour period. Values for minute ventilation (MV), tidal volume (TV), and respiratory rate (RR) were calculated from RVM data and compared to spirometry values on Day 1 and 24 hours later on Day 2.

RESULTS: After RVM monitor calibration on Day 1, accuracy for MV, TV, and RR were evaluated on Day 1 and Day 2. Across all tests and subjects, the accuracy was 11.8% for MV, 9.5% for TV, and 3.1% for RR on Day 1. On Day 2, MV showed 13.5% accuracy, while TV was 11.7%, and RR was 3.3%.

CONCLUSIONS: This monitor provides a clinically relevant non-invasive evaluation of respiratory parameters (MV, TV, and RR), delivering accuracy 24 hours after initial electrode placement. Initial data demonstrate acceptable quality for respiratory variability and complexity analysis.

CLINICAL IMPLICATIONS: Close monitoring of thoracic surgical and critical care patients is essential to prevent respiratory compromise, yet to date, monitoring the adequacy of respiration has been suboptimal in non-intubated patients. Critical decisions regarding level of pain medication and reintubation are generally made based on oxygenation data and subjective clinical examination. This monitor has the potential to bridge the monitoring gap in non-intubated patients, providing a leading indicator of respiratory deterioration to help direct timely therapeutic intervention. This could not only reduce complications, but also reduce cost of care.

DISCLOSURE: Jenny Freeman: Shareholder: Major/Ownership, Employee: CEO

Alexander Panasyuk: Shareholder: Major/Ownership, Employee: Chief Technical Officer

Michael Lalli: Shareholder: Minor, Employee: Engineer

Nicole Yocum: Shareholder: Minor, Employee: Clinical Affairs Manager

Roman Bokhenik: Employee: Engineer

Lynn Desmarais: Employee: Clinical Associate

Darren Fahy: Consultant fee, speaker bureau, advisory committee, etc.: Clinical Consultant

The following authors have nothing to disclose: Samuel Galvagno, Diane Ladd

The discussed product is a non-invasive, minimal risk respiration monitor developed by Respiratory Motion, Inc. The device used in this study is a research prototype and has not been approved by the FDA.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543